Experimental treatment does not halt fatal complication of bone-marrow transplant.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Single cell transcriptomic analysis of human mesenchymal stem cells reveals limited heterogeneity
Cell Death & Disease Open Access 08 May 2019
-
The interaction between mesenchymal stem cells and steroids during inflammation
Cell Death & Disease Open Access 23 January 2014
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Le Blanc, K. et al. Lancet 371, 1579-1586 (2008).
Related links
Rights and permissions
About this article
Cite this article
Baker, M. Stem-cell drug fails crucial trials. Nature (2009). https://doi.org/10.1038/news.2009.894
Published:
DOI: https://doi.org/10.1038/news.2009.894
This article is cited by
-
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab
Bone Marrow Transplantation (2020)
-
Single cell transcriptomic analysis of human mesenchymal stem cells reveals limited heterogeneity
Cell Death & Disease (2019)
-
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Nature Reviews Nephrology (2018)
-
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Nature Immunology (2014)
-
The interaction between mesenchymal stem cells and steroids during inflammation
Cell Death & Disease (2014)
